- Investing Ideas
- /
- Healthcare Sector
Healthcare Sector
UPDATED Apr 20, 2024
All the companies in the healthcare sector, including healthcare provider and equipment, healthcare tech, pharmaceuticals, biotech and life sciences.
2,557 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
HCA | US$305.11 | -5.5% | 8.5% | US$80.7b | US$341.19 | PE15.4x | E6.4% | 0.9% | Healthcare | ||
MCK | US$524.83 | 0.3% | 45.8% | US$69.0b | US$559.53 | PE23x | E8.7% | 0.5% | Healthcare | ||
BDX | US$234.12 | -0.4% | -10.4% | US$67.6b | US$281.23 | PE53.5x | E17.4% | 1.6% | Healthcare | ||
ZTS | US$146.50 | -2.3% | -17.2% | US$66.9b | US$218.30 | PE28.6x | E8.1% | 1.2% | Pharmaceuticals & Biotech | ||
EW | US$85.94 | -4.8% | -0.7% | US$51.7b | US$94.48 | PE36.9x | E9.2% | n/a | Healthcare | ||
DXCM | US$130.71 | -4.0% | 5.6% | US$50.4b | US$149.29 | PE93.1x | E20.2% | n/a | Healthcare | ||
COR | US$239.13 | 2.2% | 43.4% | US$47.7b | US$253.09 | PE25.5x | E7.7% | 0.9% | Healthcare | ||
SGEN | US$228.74 | 4.5% | 76.5% | US$43.2b | US$228.91 | PS18.8x | E71.8% | n/a | Pharmaceuticals & Biotech | ||
IQV | US$228.09 | -2.6% | 12.7% | US$41.5b | US$275.38 | PE30.6x | E12.7% | 0% | Pharmaceuticals & Biotech | ||
CNC | US$75.15 | 6.2% | 13.9% | US$40.2b | US$88.72 | PE14.9x | E9.0% | n/a | Healthcare | ||
HUM | US$328.33 | 5.0% | -33.2% | US$39.6b | US$390.15 | PE15.9x | E11.4% | 1.1% | Healthcare | ||
IDXX | US$476.35 | -4.3% | -3.9% | US$39.6b | US$585.81 | PE46.8x | E9.9% | n/a | Healthcare | ||
A | US$132.73 | -5.7% | -4.2% | US$38.9b | US$150.12 | PE31.5x | E9.0% | 0.7% | Pharmaceuticals & Biotech | ||
MRNA | US$101.41 | -3.5% | -28.0% | US$38.8b | US$134.30 | PS5.7x | E56.0% | n/a | Pharmaceuticals & Biotech | ||
GEHC | US$84.49 | -2.1% | -2.3% | US$38.6b | US$95.71 | PE27.8x | E14.9% | 0.1% | Healthcare | ||
VEEV | US$198.38 | -4.0% | 6.9% | US$32.0b | US$241.81 | PE60.9x | E16.6% | n/a | Healthcare | ||
BIIB | US$194.38 | -1.9% | -33.9% | US$28.3b | US$290.83 | PE24.3x | E18.2% | n/a | Pharmaceuticals & Biotech | ||
WST | US$372.04 | -2.1% | 1.7% | US$27.2b | US$390.58 | PE45.9x | E8.3% | 0.2% | Pharmaceuticals & Biotech | ||
HZNP | US$116.30 | 0.06% | 82.8% | US$26.6b | US$116.50 | PE60.8x | E16.4% | n/a | Pharmaceuticals & Biotech | ||
CAH | US$108.19 | 2.9% | 35.1% | US$26.3b | US$113.87 | PE41.2x | E15.9% | 1.9% | Healthcare | ||
RMD | US$178.85 | -3.8% | -21.6% | US$26.3b | US$206.05 | PE29.5x | E13.5% | 1.1% | Healthcare | ||
MTD | US$1,188.54 | -5.8% | -23.8% | US$25.4b | US$1,186.91 | PE32.2x | E7.7% | n/a | Pharmaceuticals & Biotech | ||
ZBH | US$119.43 | -4.1% | -13.4% | US$24.5b | US$137.15 | PE24x | E8.5% | 0.8% | Healthcare | ||
ICLR | US$288.23 | -5.8% | 39.2% | US$23.8b | US$352.79 | PE38.8x | E15.7% | n/a | Pharmaceuticals & Biotech |